… After kidney injury, it has been shown that bone marrow–derived stem cells and kidney
resident stem cells may participate in kidney repair. However, it is widely accepted that the …

… track and quantify administered cells in vivo. Acute kidney injury (AKI) is a serious and
common clinical problem with high morbidity and mortality (18). Cell therapy is a promising new …

… cells has therapeutic effectiveness in mouse models of acute kidney injury induced by
ischemia/reperfusion injury… from trophic effects by the renal progenitor cells, and it identifies the …

… determine the protection of allogeneic bone marrow mesenchymal stem cells (BMSCs) on
an ischaemia/reperfusion (I/R)‑induced acute kidney injury (AKI) rat model and to investigate …

… best route of administration, the number of cells per administration and also the number of …
and chronic kidney injury, understanding the interaction between MSCs and other tissue cells, …

… (AKI) is classically described as a rapid loss of kidney function. … Mesenchymal stem cell (MSC)
based therapies have … new alternative for treating kidney injuries. Numerous experimental …

… Current therapies for acute kidney injury remain primarily supportive and … kidney injury
were treated with bone marrow-derived, culture-expanded allogeneic mesenchymal stem cells. …

… Several studies demonstrated that mesenchymal stem cells (MSCs) reverse acute kidney
injury (AKI) by a paracrine mechanism rather than by MSC transdifferentiation. We recently …

… Cell therapy using pluripotent MSCs to treat kidney injury has … stem cells home to injured
tissue and exert their beneficial effects by differentiating into targets cells and replacing injured …

… The outcomes of the present research offer convincing evidence that stem cell-based therapy
represents the potential therapeutic approach against acute kidney injury. The success of …